• Company recently submitted NNCP application for more than 20 retail cannabis products
• Vape products will launch as part of Pure Pulls Vapes branded product line
• Demand is growing for these types of offerings, particularly in Albert, British Columbia, Ontario and Saskatchewan

With an e-cigarette market projected to reach more than $1.1 billion in 2021 with steady annual growth estimated at 4.83% through 2025 (https://ibn.fm/In9fo), the recent order of more than 30,000 high-quality vape cartridges and pens by Pure Extracts Manufacturing Corp. (“Pure Manufacturing”) seems particularly well timed. Pure Manufacturing is a wholly owned subsidiary of Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp functional mushrooms and the emerging psychedelic sector. This strategic order from a global manufacturer comes as Pure Manufacturing prepares to expand its retail offering. Pure Manufacturing recently submitted a Notice of New Cannabis Product (“NNCP”) application to Health Canada requesting approval for more than 20 retail cannabis products, including both THC and CBD vapes (https://ibn.fm/y5eMp). Pure Manufacturing intends to launch these products as part of its Pure Pulls vapes branded product line. The vape cartridges and pens, which are slated to arrive the first week of April, will be filled with a selection of some of the company’s 30-plus proprietary, full-spectrum oil formulations. Pure Manufacturing estimates that revenue potential for the shipment could reach $650,000. “We are looking forward to building our vape pen inventory in preparation for our retail launch through established provincial distribution channels,” said Pure Extracts’ CEO Ben Nikolaevsky. “At the same time, we plan to launch our Pure Chews brand of CBD and THC edible gummy products, and we have been steadily accumulating all the components from the oil extracts to the flavoring to our proprietary packages” (https://ibn.fm/Y44qO). Pure Manufacturing’s substantially expanded product line is partially in response to growing demand for these types of offerings in Albert, British Columbia, Ontario and Saskatchewan: four provinces the company is targeting for its retail launch. With quality as a top priority, Pure Manufacturing was careful to order only products that met the highest North American standards. The company specifically selected these vaping cartridges and pens based on the quality of component parts, the fit and finish, and their performance characteristics when paired with Pure Manufacturing’s oil concentrates. Pure Manufacturing is dedicated to developing its portfolio of cannabis 2.0 products. The company is particularly interested in its 30 plus proprietary formulations of Pure Pulls branded full-spectrum oil vape products and on its new line of Pure Chews edible gummies. Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming toward export sales of products and formulations—including those currently restricted in Canada—into European jurisdictions where they are legally available. In September of last year, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act. The Company’s stock began trading on the Canadian Securities Exchange (“CSE”) in November 2020. For more information, visit the company’s website at www.PureExtractsCorp.com. NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://ibn.fm/PULL

• HLTT’s Mediscan cloud-based SaaS software transforms 2D analog ultrasound images into 3D HD quantifiable formats
• Growing list of Mediscan applications include use by primary care physicians, specialists, support staff, sports trainers, EMS personnel and technicians in isolation wards and emergency rooms
• Mediscan to be offered as cloud-based medical software-as-a-service (“SaaS”)
• Patents filed with United States Patent and Trademark Office for System Method, Apparatus, and Computer Program Product for Ultrasonic Clinical Decision Support

Primary care physicians, specialists, sports professionals and emergency medical services personnel can now produce high-quality 3D digital medical images with an analog ultrasound machine through Healthtech Solutions’ (OTC: HLTT) Mediscan cloud-based software. HLTT’s Mediscan software generates 3D medical images of any body part that ultrasound technology can access, including vital organs such as the heart, lungs, kidneys, gallbladder and spleen, along with tendons and skin. The technique reconstructs analog two-dimensional grayscale visual images into digital three-dimensional, high-definition quantifiable formats in roughly one minute that can be viewed on the technician’s desktop computer, monitor, tablet or mobile phone. Mediscan has the potential to bridge the image quality gap between ultrasound technology and the significantly costlier and resource-intensive MRI, CT, and X-ray imaging techniques. The technology will empower medical professionals by providing them with data-driven metrics that enhance decision-making at the point of service. Office-based medical physicians and sports therapists will leverage the technology onsite along with emergency medical services professionals that work on-call in remote areas. Besides providing analytics to analyze the patient’s pathology or trauma, Mediscan software will facilitate treatment option decisions, help medical professionals monitor ongoing progress or regress, and assist with document compliance to ensure that all assessments meet required protocols and procedures. HLTT plans to deploy the service as a medical software-as-a-service (“SaaS”) – a model used widely in the healthcare sector whereby software is licensed on a subscription basis through a centrally hosted cloud-based vendor. Along with its use for clinical information systems, SaaS is gaining software market share in supply chain management, billing services and revenue cycle management. Favored by organizations of all sizes, SaaS is ideal for smaller operations looking to leverage world-class infrastructure without investing in external hardware or IT services. The United States medical imaging market size was recently valued at $134 billion (https://ibn.fm/64c3s) and is expected to continue growing as part of the healthcare industry’s digital transformation. As a result of the technological shift, HLTT’s management team sees a promising opportunity for Mediscan to distribute its technology and has filed patents with the United States Patent and Trademark Office through its Mediscan subsidiary for a System Method, Apparatus, and Computer Program Product for Ultrasonic Clinical Decision Support. HLTT’s mission is to produce cost-effective, high-quality 3D imaging software accessible to healthcare providers of all sizes and types across the entire healthcare industry. A growing list of use cases, coupled with increased demand for detailed medical imaging, provides a promising opportunity for the company to develop and distribute its medical imaging solutions to physicians, technicians and therapists across a wide range of specialties in the healthcare space. For more information, visit the company’s website at www.MyMediScan.com. NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

• Lottery.com offers users access to all state-sanctioned lottery games, directly in their browsers or through a smartphone app
• The company currently operates in 12 states and projects to expand to 34 states by the end of 2023; the company also plans to expand globally
• Lottery.com’s management team features serial entrepreneurs who have decades of C-level experience and extensive knowledge on producing and growing healthy organizations
• Lottery.com is gamifying charitable giving and changing how nonprofits engage with donors and raise funds through the WinTogether.org platform
• The combination of AutoLotto Inc. (dba Lottery.com) and Trident Acquisitions Corp. will allow Lottery.com to become a publicly traded company on Nasdaq under ticker symbol ‘LTRY’
• Gross revenue for Lottery.com grew at a CAGR of 363% from 2016 to 2020, leveraging a $398 billion global industry with only 6.7% online penetration; the company projects gross revenue equal to $71 million in 2021, $279 million in 2022, and $571 million in 2023

Lottery.com is a next generation platform where consumers can play the lottery online – in browser or via smartphone app. The platform offers users access to official lottery games sanctioned by their individual states and also provides lottery data to more than 400 digital publishers, including Google and Amazon Alexa. Lottery.com was founded in 2015, launching at the LAUNCH festival and soon turning into a leader in the industry. With headquarters in Austin, Texas, the company is dedicated to helping advance the lottery industry into the digital age and works closely with state regulatory bodies to achieve this goal. The company recently entered into a definitive agreement for a business combination with special purpose acquisition company Trident Acquisitions Corp. (NASDAQ: TDAC) (“Trident”), which will result in Lottery.com becoming a publicly listed company. Once the transaction is complete, the combined company will be trademarked as Lottery.com, with its common stock to remain listed on Nasdaq under ticker symbol ‘LTRY’. Lottery.com Online Platform The Lottery.com online platform works closely with state regulators, advancing the lottery into the digital age. With the online platform, the company offers enhanced regulatory capabilities by leveraging innovative blockchain technology and capturing the untapped market of digitally native players. Players go online in a browser or through a mobile application to use the interface. The process includes:

• Players Choose a Game:Players can play officially state sanctioned multi-state games and other games offered in the states in which they live. Players can also find winning numbers, jackpot totals, draw dates and more for hundreds of other lottery games around the world.
• Players Pick Numbers:Players can play their lucky numbers or do a quick pick of randomized numbers in as simple as two taps. “Tap, Tap, Ticket!”
• A Safe and Secure Way to Play:Purchases for up to 50 tickets can be made at one time through the online interface. Lottery.com handles everything after purchase, letting users know when they win.
• Collect All Winnings:Consumers keep 100% of their winnings. All winnings stay in the Lottery.com balance for future ticket purchases, or a cashout can be requested. Company representatives contact winners who hit big jackpots, instructing them on the redemption process.

A Better Way to Play the Lottery Lottery.com has an innovative e-commerce platform that is using blockchain to maintain an accurate ledger. From 2016 to 2020, Lottery.com grew gross revenue at a CAGR of 363%, and it forecasts gross revenue equal to approximately $71 million in 2021, $279 million in 2022, and $571 million in 2023. Lottery.com is leveraging a successful playbook, with $398 billion in global lottery sales but only 6.7% online penetration. The large market opportunity is expected to shift to online transactions within the next decade. The platform is currently available in 12 states across the United States, and the company plans to expand to 34 by the end of 2023. Global expansion is also on the horizon, with partnership plans in Turkey and Ukraine. Key features that make the Lottery.com experience unique include:

• All the Games Users Love– For consumers who live in applicable LIVE states, Powerball and Mega Millions are available right from the mobile application.
• Convenience– Lottery.com makes playing the lottery on mobile devices easy. After setting up an account, users can begin playing in moments or set reminders to play when the jackpot is high.
• Easy Cashouts– Users can cash out winnings straight to a bank account, safely and securely, with no commissions.

The company is also gamifying charitable giving, fundamentally changing how nonprofits engage with donors and raise funds. WinTogether.org is a platform designed to offer charitable donation sweepstakes to incentivize donors to take action by offering large cash prizes and once-in-a-lifetime experiences. Strong Advisory Board Presence Lottery.com is expected to continue to gain support, leaning on the experience of its advisory board and notable investors from the venture capital, gaming and entertainment industries. These include:

• Jason Robins, CEO of DraftKings Inc. (NASDAQ: DKNG)
• Ben Narasin, Venture Partner of NEA
• Peter Diamandis, Chairman of XPRIZE Foundation
• Matthew Le Merle, Co-Founder and Managing Partner of Fifth Era and Keiretsu Capital
• Paraag Marathe, President of Enterprises and EVP of Football Operations for the San Francisco 49ers
• Jamie Gold, The Poker Philanthropist

Management Team Tony DiMatteo is the Co-Founder and Chief Executive Officer of Lottery.com. He is a serial entrepreneur and highly sought-after industry speaker and thought leader. He has been featured in The Wall Street Journal, Forbes, VentureBeat, TechCrunch Inc. and more for his approach to entrepreneurship, the gaming industry and cryptocurrency. Matt Clemenson is the Co-Founder and Chief Commercial Officer of Lottery.com. He is responsible for the company’s strategy. Mr. Clemenson was steeped in corporate and enterprise engineering processes at Hotwire and Expedia before going on to be CEO at LesConcierges, the world’s largest concierge company, which merged into John Paul and sold to Accor Hotels. Clemenson and DiMatteo have been partners for more than 10 years. Ryan Dickinson is the company’s President and Chief Operating Officer. He has a diverse background in business, technology, product, design and sales, which has aided him in producing many successful outcomes throughout his career. Notably, as Senior Vice President of a SaaS company, Mr. Dickinson produced profitability from a negative $1.4 million division within the first year by reinventing the product offerings, streamlining processes and establishing a go-to-market strategy. Additionally, he produced three record breaking revenue years in a row for AccuWeather, the world’s largest weather provider, by increasing every KPI for all flagship properties by no less than 5%. Luc Vanhal is the company’s Chief Financial Officer. He has served in C-level executive roles since the 1990s, including a nine-year tenure for The Walt Disney Company (NYSE: DIS) from 1990 to 1999. From 2001 to 2004, he managed the development of the World of Warcraft massively multiplayer game, which, by the end of 2020, still had over five million active subscribers. As the CFO of Lottery.com, Mr. Vanhal leads the company’s global finance organization, with treasury responsibility, accounting, analysis and financial planning. For more information, visit the company’s website at www.Lottery.com. NOTE TO INVESTORS: The latest news and updates relating to Lottery.com are available in the company’s newsroom at https://ibn.fm/Lottery

• Imagin Medical believes the i/Blue System can revolutionize the current standard of care for bladder cancer patients by improving cancer visualization for removal, and potentially lowering recurrence rates
• Imagin Medical is leveraging the significant expertise in optics, electronics, software, and mechanical design of FDA-registered contract manufacturer, Lighthouse Imaging, to implement the final stage of the i/Blue(TM) Imaging System
• Lighthouse’s manufacturing program remains on track for product commercialization in 2022

Surgical imaging company Imagin Medical (CSE: IME) (OTCQB: IMEXF) is continuing progress with the commercial-stage manufacturing  of its patented i/Blue Imaging System, an innovative technology that the company believes will revolutionize the way surgeons visualize the bladder and identify cancers during minimally invasive surgery. The company has been working with contract manufacturer, Lighthouse Imaging, to complete the system for commercialization. In a company press release, Imagin Medical’s President and CEO, Jim Hutchens, said the COVID-19 pandemic impacted the company’s production timeline by approximately nine months, which moved product completion into 2022. “The good news is that Lighthouse’s program has stayed on schedule and we expect it to remain on target going forward,” Hutchens added (https://ibn.fm/rHZFl). Lighthouse Imaging’s development program is focused on refining the i/Blue System’s design after Imagin Medical received multiple fully functional feasibility units from original design partner, Optel, Inc. The patented, ultrasensitive imaging technology behind  i/Blue employs advanced light sensors and optics to enhance visibility and aid in the removal  bladder cancer, the sixth most prevalent form of cancer in the United States and, the most expensive to treat because of high recurrence rates. Surgeons traditionally perform cystoscopies to visualize and diagnose bladder cancer during surgery. Most cystoscopies use white light to illuminate the bladder, a technique that has been used for decades and is the standard for 90 percent of the market. For its many benefits, white light has the disadvantage of only highlighting cancerous tumors that protrude above the bladder wall. This makes it difficult to identify flat tumors because of the inability to distinguish between healthy tissue and tumors. This drawback has been addressed with the introduction of blue light with a contrast imaging agent that highlights the cancer to detect flat tumors, but blue light images are not in real time, which makes it impossible to operate using blue light images alone. For the surgery to be effective, surgeons need to manually switch back and forth from white to blue light images, requiring the surgeon to resect the tumor from memory when they switch back to the white light. Imagin Medical’s i/Blue System can correct the limitations of today’s white and blue light cystoscopy procedures. Combining the same FDA-approved imaging agent with white and blue light, the innovative technology allows surgeons to view both white and blue light images side-by-side simultaneously on the monitor during the procedure, which means they do not have to switch back and forth. Additionally, the technology is highly versatile and can be attached to most endoscopes on the market, which means hospitals would be able to adopt the visualization system without having to replace their current instruments, resulting in significant cost savings. The company believes this technology has the potential to revolutionize the current standard of care for bladder cancer patients by advancing the efficiency and accuracy of cancer detection and removal, and potentially reducing recurrence rates.  Imagin plans to build on the i/Blue technology to expand its use in multiple endoscopic procedures, including laparoscopic, colorectal and thoracic procedures that use a variety of contrast dye agents and illumination sources. Imagin’s FDA approval process is supported by certified manufacturer Lighthouse Imaging’s manufacturing program, which aims to ensure i/Blue System’s compliance with all applicable regulatory standards, as well as final device performance and manufacturability to meet anticipated demands and cost targets. Director of Engineering and Quality, Mike Vergano, voiced appreciation for the Lighthouse team’s expertise and exceptional work to date and added “We chose Lighthouse because of its accomplished history of taking innovative products like our i/Blue System and applying its cross-functional expertise in optics, electronics, software and mechanical design to move into commercial manufacturing,” he explained, underlining that the results so far have not been disappointing and expects the same going forward. For more information, visit the company’s website at www.ImaginMedical.com. NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• Fan Pass was ten artist signups away from surpassing February totals at the middle of March, topping 300 artist signups
• The company is preparing for several events, technology advances, and release updates in the near future
• Social media engagement has increased across the board, including external Instagram accounts that Fan Pass has reached going up 139.2%
• The global live streaming market is expected to reach $247.3 billion by 2027, growing at a CAGR of 28.1%

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, recorded a significant number of acquisitions and increased social media activity for the first half March so far, just ten artist signups short of surpassing February totals. According to a press release, the company’s live event calendar has been regularly filling up, while the metrics provided by social media continue to validate the appetite for the Fan Pass offering (https://ibn.fm/UmjlL). “It’s only the midway point of March, and with momentum like this we felt it was important to share a brief update as the Company prepares for several exciting events, technology advances, partnerships and release updates coming soon,” said Friendable CEO Robert A. Rositano Jr. The social media indicators show that the Fan Pass Facebook page is up to 96% reach, post engagements are up 70%, and page likes are up 100%. The external Instagram accounts Fan Pass has reached are up 139.2%, with content interactions up 41.7%. Over the previous 30-day period, Instagram followers (@fanpasslive) have increased by 9.7%. The March artist contest is currently underway, offering the first 50 artists who schedule, promote, and complete a live event an incentive of $50. This amount is on top of the current first, second, and third place prizes for the artists with the most viewers during the month.

• 1st Place: GoPro HERO9 or $300 cash
• 2nd Place: Streaming kit ($250 value) or $150 cash
• 3rd Place: Custom design ($100 value) or $50 cash

Supporters can also take advantage of the Fan Pass merchandise sale for March with $10 t-shirts (promo code: MARCH5). In addition, Rositano thanked both current and future artists signing up for the platform, underlining that some artists even created thank-you and promotional videos to show their appreciation for the Fan Pass team. “We are nothing without our artists, supporters and shareholders; we are here to make a difference, and doing it together is a very motivating and rewarding experience for our entire team,” he added. Fan Pass features an All-Access VIP subscription for fans to stay connected with their favorite artists and discover new artists to follow all on one platform. The All-Access VIP experience offers fans:

• Live performances and/or online concerts
• Backstage experiences before, after, and even during events
• Studio session live streams
• Behind-the-scenes footage both on and off the sets of music videos and photoshoots
• Special interviews
• Streams that highlight the day in the life of the artist
• And more!

Two packages are currently available for fans. The monthly All-Access VIP is $4.99, or fans can subscribe annually and save 20%, paying only $38.30 for the year. Not only does Fan Pass give fans access to the artists they love, but it also provides them with access to merchandise and other content they wouldn’t get outside of an online platform. Artists can sign up for free, with various Artist Pro Service packages available for promotional purposes. Artists earn revenue for ticket sales and a portion of the subscription amount paid by fans who subscribe to the Fan Pass platform. This unique model and its commitment to helping artists and fans maintain engagement will help Friendable position itself as a prominent player on the global live streaming market. Consumers worldwide have constantly increased how much content they live stream since 2019. The global market is expected to reach $247.275 billion by 2027, growing at a CAGR of 28.1% (https://ibn.fm/mt9I1). The pandemic has played a huge role in the increase of live streamed content. With venues closing due to the threat of COVID-19, more artists are turning to online platforms to connect and engage fans. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Autonomous security robot (“ASR”) developer Knightscope is manufacturing and deploying a cadre of unsleeping sentinels designed to patrol perimeters and report their findings to human operators
• The company’s ASRs were recently honored with a second-place award in the area of “passenger experience” by the government’s Transportation Security Administration as part of its Power of Passengers Challenge
• Knightscope’s platform delivers revolutionary tools for a stressed industry during a time of increasing threats to Americans’ safety
• Knightscope’s founders developed their mission in response to threats such as the Sandy Hook Elementary School mass shootings, and the domestic terror bombing of the Boston Marathon
• The company currently deploys three models that respond to client needs in a variety of ways, using AI technology and camera, heat-sensing and communications resources to gather and distribute information

Twenty years after the September 11 terrorist attacks on Americans and their government, the country continues to grapple with the challenges of ensuring greater security to travelers as well as company and agency infrastructures. In response to these issues, the Transportation Security Administration (“TSA”) wing of the Department of Homeland Security (“DHS”) recently fielded competitors in its private industry Power of Passengers Challenge to pursue innovations for improving security screenings, situational and/or operational awareness, passenger arrivals, international arrival transfers and COVID-19 recovery. Autonomous security robot (“ASR”) developers at Knightscope were honored with a second-place award in the area of “passenger experience,” which included a $20,000 cut of the event’s prize fund (https://ibn.fm/maTEO). “We could not be more honored to have our efforts recognized by the Transportation Security Administration. It is another step forward on our mission to helping make the United States of America become the safest country in the world,” Knightscope Chairman and CEO William Santana Li stated (https://ibn.fm/lPvHX). Knightscope was formed in April 2013 by Santana Li and Stacy Dean Stephens in response to the bombing at the Boston Marathon and the tragic shootings at Sandy Hook Elementary School that had occurred during the previous year. Recent unrest in response to shootings involving police officers has only added fuel to their inner fire. “What really gets me fired up (is) I was born in New York City and someone hit my town on 9/11. And I’m still profoundly pissed off about it, so I dedicated the rest of my life to better securing our country,” Santana Li said in a new company video biopic (https://ibn.fm/AWn4b). “Additionally the mass shooting violence across the country is not acceptable. … Our country is under attack. I was livid then and I’m even more furious now.” Santana Li notes that crime has more than a trillion-dollar negative economic impact on the United States every year. Knightscope’s response came in the form of autonomous sentry robots that provide property perimeter vigilance 24 hours a day, 365 days a year — an unarmed and unthreatening presence, but one uniquely capable of perceiving, recording and transmitting information to security personnel overseers and law enforcement. The robots are even capable of providing a barrier to virus transmission between humans during the pandemic. The company’s K1 stationary robot, its mobile indoor K3 model and its outdoor patrolling K5 are capable of streaming live video from a 360-degree perspective, visualizing dark and unseen areas with heat-sensing and thermal-imaging cameras, monitoring communications frequencies, and using AI to recognize targets of specific interest. Its speakers are also capable of communicating messages from operators in real time. Knightscope thereby provides the tools to security forces to more effectively cover more area with less risk to personnel. The CEO noted that providing better security tools to government agencies, companies and perhaps even individuals will impact society across a broad spectrum of interests, from insurance rates to housing prices, from school budgets to financial markets. “Long-term, I dream of building a $30 billion equivalent to a defense contractor, you know, something similar like Lockheed-Martin or a Boeing or General Dynamics or a Raytheon, except focus on helping the U.S. Department of Homeland Security and the U.S. Department of Justice better secure our country with a wide-ranging portfolio of new ground-breaking technologies,” Santana Li said. “I think it is possible.” For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• SRAX Inc. reveals that entrepreneur and 2020 presidential candidate, Brock Pierce, is joining Company’s Board of Directors
• Pierce has been involved with over 100 companies as an entrepreneur, and was formerly involved in sale of Five Delta to SRAX in 2014
• Pierce will bring a significant track-record in capital markets along with him, essential skill sets which will benefit ongoing development of SRAX’s Sequire platform

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, revealed that entrepreneur, philanthropist and 2020 presidential candidate Brock Pierce has joined the SRAX board of directors. Pierce will be replacing Malcolm CasSelle, the former CEO of BIGtoken, who passed away in November of 2020. Brock Piece has a long and illustrious track record as an entrepreneur, having co-founded, advised, and funded over 100 companies, which in turn, has led to the creation of new employment opportunities and marketplaces through technological innovation, including the use of novel blockchain technologies. Pierce also boasts a lengthy association with SRAX, having been responsible for the formation of Five Delta, a company purchased by SRAX in 2014 which held a number of patents centered around social media ad targeting. The Five Delta team and the company’s technological solutions would go on to form SRAX MD, a company which would ultimately be spun off by SRAX to private equity buyers in 2018 for a gross consideration approximating $50 million. “Brock Pierce is one of the smartest people and one of the most significant visionaries I have ever met,” said SRAX CEO and Founder Christopher Miglino. “He has been able to see trends early and has been able to capitalize on those insights. We are honored to have him join our Board of Directors and are especially honored to have him replace the seat left behind from the passing of Malcolm CasSelle whom we loved, respected, and miss daily.” SRAX has recently centered its operational efforts around Sequire, the Company’s proprietary investor intelligence platform which has grown to boast over 3 million retail investors. Launched as a standalone platform in early 2020, Sequire has attracted over 91 publicly listed companies as subscribers (https://ibn.fm/YiXuZ), many of which have benefited from the unparalleled access to a vast universe of untapped investors. Retail investors have been increasingly active within the U.S. equity market over the past year, with brokerage TD Ameritrade revealing last year that it had seen nearly 1.76 million retail accounts opened during January through September of 2020—a record amount for the company over the first nine months of a year. Meanwhile, Goldman Sachs strategists recently raised their 2021 net equity demand estimates from US households from $100 billion to $350 billion (https://ibn.fm/LBfGb) in reflection of the growing number of retail investors. “SRAX is changing the way that investors interact with public companies and fundamentally changing the interaction between the retail investor and the capital markets,” said Brock Pierce. “This year, more than ever, the strength of the retail investor has become apparent to the board room. SRAX is at the forefront of this shift, and I look forward to sharing my capital markets experience with the team,” he concluded. For more information, visit the companies’ website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• HempFusion Wellness Inc. has announced the launch of certain Probulin Probiotics products in China to be sold on Alibaba Group Holding’s Tmall Global
• Tmall offers a number of features and advantages, which will be pivotal in helping HempFusion earn significant revenue
• Probulin Probiotics is recognized as one of the fastest-growing probiotics brands in the United State Natural Products Industry, according to SPINS syndicated data, and by entering the Chinese market, HempFusion hopes to replicate this growth in the vast Chinese marketplace

The Chinese probiotics market is booming and is expected to reach $12.75 billion in 2022, up from $6.47 billion in 2017 (https://ibn.fm/FCQdc). Moreover, with more and more people in China appreciating the health benefits associated with the use of probiotics, according to a 2020 survey (https://ibn.fm/cg0TQ), the conditions seem favorable for HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 800) through its wholly-owned subsidiary, Probulin Probiotics, LLC, to thrive. In a recent news release, HempFusion, a leader in the health a wellness cannabidiol (“CBD”) industry, announced that it would target this Chinese market through Probulin (https://ibn.fm/pfsfT). Probulin will offer certain products on Alibaba Group Holding’s Tmall Global, with shipments expected to commence in late March. Thereafter, HempFusion’s Probulin products will be available for purchase – the go-live date is currently set at March 29. The choice of this date is strategic for HempFusion as it will ensure that the Probulin products are purchasable before the mid-year 618 shopping festival, one of China’s largest single-day shopping extravaganzas, which is usually held in June. In 2020, it shattered records with over $98.52 billion in sales in 24 hours. By tapping into the massive Chinese market, HempFusion anticipates a significant revenue increase. “This strategic launch provides us with a tremendous opportunity to reach one of the largest online consumer bases in the world and drive significant revenue for the company,” said Jon Visser, HempFusion’s Chief Revenue Officer. This is thanks, in part, to the features and benefits offered by Tmall Global. Tmall Global is the world’s largest cross border online marketplace that enables foreign-based vendors to access the Chinese market, reaching more than 750 million potential consumers in mainland China, Hong Kong, Macau and Taiwan. The platform provides a win-win situation for both the sellers and consumers as the Chinese consumers, whom the vendors target, have a high affinity for imported products, which they consider as being high-quality. Tmall also leverages Alibaba’s elaborate consumer analytics tools to provide the sellers with insights into Chinese consumers’ shopping behavior (https://ibn.fm/Klibc). While these features and benefits are some of the reasons why HempFusion may have chosen Tmall, perhaps the most significant – because of its potential to influence sales and revenue – is that the platform regularly engages consumers with brands through live streaming, educational videos and group chats. HempFusion and Probulin could take full advantage of this, given that most Chinese consumers lack product understanding of probiotics despite acknowledging their health benefits. “Although China’s probiotics market is booming, consumers are not well-equipped in terms of scientific knowledge,” reads an article summarizing the findings of a report on the probiotics market in China. “One of the major knowledge gaps is not knowing the differences between probiotics, prebiotics and lactic acid bacteria.” With the interactive tools on Tmall, it would be befitting for Probulin to use the platform to bridge the knowledge gap. By creating awareness, HempFusion would surely appeal to more buyers, translating to additional revenue. “Probulin looks forward to utilizing our growing team of celebrity influencers to take advantage of these innovative, interactive opportunities to reach new consumers in a fun and entertaining way,” Visser continued. On his part, Dr Jason Mitchell, N.D., HempFusion’s co-founder and CEO, hailed the launch as a tremendous milestone that would also be an opportunity to educate the Chinese market on the many health benefits of probiotics. “We believe Probulin to be the first American company to deliver cold and protected probiotic supplements direct to Chinese consumers,” Dr Mitchell stated. “In addition, our scientifically validated MAKTrek® 3-D Probiotic Delivery System is designed to protect and nourish the probiotics so that more can arrive alive in the gut. These two distinguishing factors result in a positive influence on the microbiome and overall wellness.” HempFusion’s Probulin is recognized as one of the fastest-growing probiotics brands in the United States Natural Products Industry according to SPINS syndicated data. With its strategic entry into the Chinese market and the favorable conditions therein, the company may replicate this growth in the new territory. HempFusion also recently announced that its OTC Topical Products were ranked number one in both sales dollars and units sold at a major Food & Drug Mass (“FDM”) retailer according to a recent NielsenIQ share report (https://ibn.fm/bScHY). For more information, visit the company’s website at www.HempFusion.com/corporate-information. NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://ibn.fm/CBDHF

• COVID-19 patients can suffer from bevy of ailments from fatigue to cardiac conditions long after virus has left their body
• Follow-up monitoring is not convenient or cost effective
• Mediscan, subsidiary of Healthtech Solutions, has brought to market a solution that has potential to become standard of care, including helping emerging “long hauler” crisis
• Mediscan’s technology converts two-dimensional ultrasound images into 3D, high-definition format in under one minute for immediate attention at point of care

Call them “long haulers” or people with “long COVID” or any other number of names, but don’t call anyone “recovered” even though coronavirus free. There is a growing chorus of patient voices and published studies suggesting at least half (and potentially up to 80%) of COVID-19 patients continue to exhibit troublesome symptoms that affect their quality of life long after tests show no viral load present (https://ibn.fm/JevnA). While all too often dismissed by physicians, awareness of the chronic symptoms has earned the attention of the National Institutes of Health, which has proposed “post-acute sequelae of SARS-CoV-2 infection (‘PASC’)” as an all-encompassing name for the malady. Symptoms can range from chronic fatigue to cardiac conditions, highlighting the need for widespread adoption of simple and fast standards of care to monitor organs and tissue to best understand a patient’s condition. That’s exactly what upstart Mediscan Inc., a subsidiary of Healthtech Solutions (OTC: HLTT), is bringing to the table with its innovative software application that converts two-dimensional ultrasound images into a 3D, high-definition format in under one minute for immediate attention at the point of care. Mediscan is bridging a big gap in healthcare today where access to magnetic resonance imaging (“MRI”) and computed tomography (CT or CAT) machines often aren’t readily available, much less convenient for immediate care. The poignant fact is that many of those facilities try to avoid even having COVID-positive patients on site—that goes without mentioning the high costs for those tests. An MRI in the U.S. in 2019 averaged $2,611, according to GE Healthcare citing Time Magazine (https://ibn.fm/JDkNE). CT scans can cost up to $3,275 (www.NewChoiceHealth.com). Mediscan is looking to disrupt the $134 billion U.S. medical imaging market (https://ibn.fm/XaPCv) with its cloud-based software that reconstructs an ultrasound’s analog 2D grayscale image into digital 3D HD format nearly instantly. For the first time, medical professionals will have at their fingertips images containing data-driven metrics that previously were only available through X-rays or MRI and CT scans. A video discussing the technology is available for viewing online (https://ibn.fm/cpumJ). Applications abound for the user-friendly technology, including a physician’s office, sporting facilities and events, isolation wards, emergency rooms and on-location for emergency medical services (“EMS”) personnel, to name a few. Anywhere an internet signal can be used – which is nearly everywhere anymore thanks to hot spots – once certified, the Mediscan technology will be able to provide almost immediate, actionable information on heart, lungs, tendons, skin and other organs. Furthermore, the Mediscan app integrates with all the popular electronic medical record (“EMR”) systems for comprehensive record keeping. An opportunity is present for market penetration by utilizing the technology for PASC with any of the nearly 30 million Americans diagnosed with COVID-19 for an easy point-of-care diagnostic that is reliable and repeatable to track progression or regression without the inconvenience and high cost of legacy technologies. Once in the doctor’s office and other locations, it’s hard to imagine Mediscan not becoming an integral part of patient care, where a doctor or nurse could say, “Let’s take a closer look” and have data in a matter of minutes using only a portable ultrasound device and the Mediscan app. For more information, visit the company’s website at www.MyMediScan.com. NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

• PACR recently closed share purchase agreement to acquire Lords of Grasstown Holdings Ltd.
• Lords of Grasstown is iconic brand with loyal following anchored in motorcycle culture of Pacific Northwest
• PACR closed non-brokered private placement with aggregate gross proceeds of $1,340,685.90

Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated to producing premium-quality strains and products through a genetics-focused approach, recently announced the closing of a share purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd. whereby the company will acquire all its issued and outstanding shares. The company also announced the closing of its previously announced non-brokered private placement with aggregate gross proceeds of $1,340,685.90 to be used for business and brand development, and as general working capital. Grasstown is a well-established brand that fuses motorcycle and cannabis culture. Spawned from the vision of Tyler Hazelwood, the founder and director of the iconic Lords of Gastown brand, Grasstown has built a loyal following anchored in the motorcycle culture of the Pacific Northwest. The total purchase price pursuant to the share purchase agreement will be comprised of a cash payment of $50,000 that will be payable within 30 days of the closing date along with the issuance of 6,000,000 common shares of the company within five business days of the transaction closing date. “This acquisition marks a major milestone for the company with a move into the U.S. Cannabis Market, predominantly in California, with the Grasstown Brand,” said Pac Roots CEO Patrick Elliott (https://ibn.fm/noGUJ). “The team at Lords of Grasstown have done a remarkable job branding, designing, launching and marketing Grasstown in B.C. and California. “The alliances are real and the followers like what they see,” he said. We are thrilled to develop and expand Grasstown from Prince Rupert to San Diego. Tom and Tyler are authentic artists with a strong pedigree to prove it. We are inspired to have them as part of the team.” PACR also announced the closing of its non-brokered private placement that raised $1,340,685.90 in aggregate gross proceeds through the issuance of 7,448,255 units, each consisting of one common share and one purchase warrant with the latter exercisable at $0.30 per share until February 23, 2024 (https://ibn.fm/sPg56). Registrants were paid finder’s fees of $75,294.51 in cash along with 408,303 finder’s warrants that are exercisable into one common share at $0.18 per share until February 23, 2024. All private placement securities are subjected to a four-month hold period that expires on June 24, 2021. Pac Roots Cannabis Corp. is a Canadian cannabis company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach. The company focuses on elite cannabis genetic development for maximum yields, high profit margins, and superior quality strains that meet the high standards of the growing cannabis market. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR